Cancer

MI-Healthy City Tool helps communities promote health equity across Michigan

The MI-Healthy City Tool, developed by researchers at the University of Michigan School of Public Health, is a comprehensive dashboard analyzing health equity in Michigan's largest cities to inform policy and community action.

Rogel Cancer Center names Baladandayuthapani as associate director for quantitative data sciences

Baladandayuthapani will facilitate cancer research efforts using biostatistics, bioinformatics, computational biology and other advanced data science approaches.

9 million Medicare beneficiaries to benefit from new drug pricing, but careful monitoring needed, says U-M researcher

Michigan Public Health professor and researcher Minal Patel discusses the US Department of Health and Human Services’ move to lower prices on for 10 high-cost medications for individuals with Medicare Part D coverage.

New AI-powered statistics method has potential to improve tissue and disease research

Research team hopeful that the method, called IRIS, can provide more detailed information for precision health treatment plans and health outcomes.

Researchers at the University of Michigan and Brown University have developed a new computational method, IRIS, to analyze complex tissue data which could transform our current understanding of diseases and how we treat them.

HPV self-sampling key for cancer screening in transgender patients

New research from Andrew Brouwer

Two studies published in the journal LGBT Health shed light on the acceptability and necessity of human papillomavirus (HPV) self-sampling as a method for cancer screening among transgender and gender diverse individuals assigned female at birth.

Statewide effort to study how environment affects cancer risk

Researchers at Michigan Public Health and the U-M Rogel Cancer Center plan to use a $13 million grant from the National Cancer Institute to study how exposures to toxic metals are impacting the cancer risk of Michigan residents.